PropNotes

WHOOOO WHEEEE - JPM Calling NVAX To 275 Today On Drug Data

Short
NASDAQ:NVAX   Novavax, Inc.
This is one of the more insane calls I've seen of late. Last night NVAX released drug data which was interpreted as a huge positive, and thus the stock is rallying this morning, especially following a JPM call that the company's fair value is $275. That's quite a bit of headroom from where we are now, and also about 70% upside from yesterday's close. A quick look at the momentum suggests that we might actually get there, but personally I'm skeptical. I'm not convinced that the winner of the Covid - 19 virus race will actually rake in profits from it, given how political finding the cure is, and how it seems unlikely that it will be sold for anything but at cost, probably around $10. Just some speculation. Definitely a situation to keep an eye on though. I''m looking for a slowing in momentum before shorting it.

🚨🚨🚨

Looking for the next big move?

Supercharge your profits with our high-quality trade ideas and investment research.

Try it for free: www.propnotes.co/
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.